Evidence map›Paper›PMID 14513276›Full record

ReviewDer Pathologe2003

[Neuroendocrine tumors of the gastrointestinal tract].

G Klöppel

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Der Pathologe, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

G KlöppelInstitut für Allgemeine Pathologie und Pathologische Anatomie, Universitätsklinikum Schleswig-Holstein, Kiel. gkloeppel@path.uni-kiel.de

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diffuse neuroendocrine cell system of the gastrointestinal tract gives rise to the neuroendocrine neoplasms. The WHO classification distinguishes between well differentiated neuroendocrine tumors of benign or uncertain behavior, well differentiated neuroendocrine carcinomas of low grade malignancy and poorly differentiated neuroendocrine carcinomas of high grade malignancy. The well differentiated neuroendocrine tumors and carcinomas correspond to the carcinoids of earlier classifications. Further biological and prognostic classification of these neoplasms must consider the localization of the tumors within the gastrointestinal tract. This system allows a clinically relevant diagnosis and includes all so far known tumor entities.

Indexed as

Carcinoid TumorCarcinomaCell DifferentiationGastrointestinal NeoplasmsHumansNeoplasm InvasivenessNeuroendocrine TumorsPrognosisWorld Health Organization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.